{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T05:11:07Z","timestamp":1772169067792,"version":"3.50.1"},"reference-count":11,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["f1000research.com"],"crossmark-restriction":false},"short-container-title":["F1000Res"],"abstract":"<ns4:p>Polymyositis is a rare disease with incidence rates at about 1 per 100,000 people annually. In this case report we will review a case of proximal muscle weakness with an elevated creatine phosphokinase that was initially misdiagnosed twice as rhabdomyolysis. Therefore, emphasizing that idiopathic inflammatory myopathy is a potential cause of myasthenia that must be considered in the differential. The case will also describe the current treatment and treatment response in polymyositis.<\/ns4:p>","DOI":"10.12688\/f1000research.7681.1","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T05:35:08Z","timestamp":1455255308000},"page":"164","update-policy":"https:\/\/doi.org\/10.12688\/f1000research.crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Elevated CPK, an indicator of idiopathic inflammatory myopathy?"],"prefix":"10.12688","volume":"5","author":[{"given":"Hina N.","family":"Khan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usman","family":"Jilani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shitij","family":"Arora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2560","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"ref-1","doi-asserted-by":"publisher","first-page":"158-169","DOI":"10.1186\/cc2978","article-title":"Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians.","volume":"9","author":"A Huerta-Alardin","year":"2005","journal-title":"Crit Care."},{"key":"ref-2","doi-asserted-by":"publisher","first-page":"83-105","DOI":"10.1016\/j.mayocp.2012.10.017","article-title":"Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.","volume":"88","author":"F Ernste","year":"2013","journal-title":"Mayo Clin Proc."},{"key":"ref-3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/2044-5040-3-13","article-title":"Idiopathic inflammatory myopathies: pathogenic mechanisms of muscle weakness.","volume":"3","author":"S Rayavarapu","year":"2013","journal-title":"Skelet Muscle."},{"key":"ref-4","doi-asserted-by":"publisher","first-page":"349-356","DOI":"10.1007\/s11940-003-0025-9","article-title":"Dermatomyositis and polymyositis.","volume":"5","author":"H Briemberg","year":"2003","journal-title":"Curr Treat Options Neurol."},{"key":"ref-5","doi-asserted-by":"publisher","first-page":"971-982","DOI":"10.1016\/S0140-6736(03)14368-1","article-title":"Polymyositis and dermatomyositis.","volume":"362","author":"M Dalakas","year":"2003","journal-title":"Lancet."},{"key":"ref-6","doi-asserted-by":"publisher","first-page":"638-656","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis.","volume":"51","author":"A Findlay","year":"2015","journal-title":"Muscle Nerve."},{"key":"ref-7","doi-asserted-by":"publisher","first-page":"134-153","DOI":"10.1111\/j.1749-6632.2009.05119.x","article-title":"Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis.","volume":"1184","author":"A Mammen","year":"2010","journal-title":"Ann N Y Acad Sci."},{"key":"ref-8","doi-asserted-by":"publisher","first-page":"344-347","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts).","volume":"292","author":"A Bohan","year":"1975","journal-title":"N Engl J Med."},{"key":"ref-9","doi-asserted-by":"publisher","first-page":"h5079","DOI":"10.1136\/bmj.h5079","article-title":"Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?","volume":"351","author":"C Mohan","year":"2015","journal-title":"BMJ."},{"key":"ref-10","doi-asserted-by":"publisher","first-page":"1177-1179","DOI":"10.1136\/jnnp.2005.078345","article-title":"The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy.","volume":"77","author":"D Bonifati","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"ref-11","doi-asserted-by":"publisher","first-page":"1187-1190","DOI":"10.1136\/jnnp.2005.081810","article-title":"Expression of granulysin in polymyositis and inclusion-body myositis.","volume":"77","author":"K Ikezoe","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry."}],"container-title":["F1000Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/f1000research.com\/articles\/5-164\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-164\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/f1000research.com\/articles\/5-164\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T13:55:58Z","timestamp":1544018158000},"score":1,"resource":{"primary":{"URL":"https:\/\/f1000research.com\/articles\/5-164\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":11,"URL":"https:\/\/doi.org\/10.12688\/f1000research.7681.1","relation":{"has-review":[{"id-type":"doi","id":"10.5256\/f1000research.8271.r15273","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.8271.r13251","asserted-by":"subject"},{"id-type":"doi","id":"10.5256\/f1000research.8271.r15273","asserted-by":"object"},{"id-type":"doi","id":"10.5256\/f1000research.8271.r13251","asserted-by":"object"}]},"ISSN":["2046-1402"],"issn-type":[{"value":"2046-1402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]},"assertion":[{"value":"Indexed","URL":"https:\/\/f1000research.com\/articles\/5-164\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.5256\/f1000research.8271.r13251, Martin Aringer, Department of Medicine III, University Medical Center Carl Gustav Carus, TU Dresden, Dresden, 01307, Germany, 05 May 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-164\/v1#referee-response-13251","order":0,"name":"referee-response-13251","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.5256\/f1000research.8271.r15273, Xenofon Baraliakos, Department of Rheumatology, Ruhr University Bochum, Herne, Germany, 28 Jul 2016, version 1, indexed","URL":"https:\/\/f1000research.com\/articles\/5-164\/v1#referee-response-15273","order":1,"name":"referee-response-15273","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":2,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}